enVVeno Medical (NVNO) Notes Payables (2017 - 2021)
enVVeno Medical's quarterly Notes Payables came in at $312700.0 in Q2 2021, little changed year-on-year from $312700.0 in Q2 2020, and little changed quarter-over-quarter from $312700.0 in Q1 2021.
enVVeno Medical has reported Notes Payables for 3 years, with the latest figure at $312700.0 in Q2 2021.
- For the quarter ending Q2 2021, Notes Payables changed 0.0% year-over-year to $312700.0; the trailing twelve-month figure through Jun 2021 stood at $312700.0 (changed 0.0% YoY), and the FY2020 full-year result was $312700.0, changed N/A from the prior year.
- Notes Payables for Q2 2021 stood at $312700.0, roughly flat from $312700.0 in the prior quarter.
- The five-year high for Notes Payables was $312700.0 in Q2 2020, with the low at $275000.0 in Q4 2017.
- Average Notes Payables over 3 years is $306416.7, with a median of $312700.0 recorded in 2020.
- Peak annual rise in Notes Payables reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
- Tracing NVNO's Notes Payables over 3 years: stood at $275000.0 in 2017, then grew by 13.71% to $312700.0 in 2020, then changed by 0.0% to $312700.0 in 2021.
- The last three Notes Payables figures came in at $312700.0 (Q2 2021), $312700.0 (Q1 2021), and $312700.0 (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | enVVeno Medical | 6.99 Mn | 6.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 312,700.00 |
| Mar 31, 2021 | 312,700.00 |
| Dec 31, 2020 | 312,700.00 |
| Sep 30, 2020 | 312,700.00 |
| Jun 30, 2020 | 312,700.00 |
| Dec 31, 2017 | 275,000.00 |